[go: up one dir, main page]

ATE539351T1 - Verfahren zur schnellen beurteilung der schwere eines traumas - Google Patents

Verfahren zur schnellen beurteilung der schwere eines traumas

Info

Publication number
ATE539351T1
ATE539351T1 AT07722631T AT07722631T ATE539351T1 AT E539351 T1 ATE539351 T1 AT E539351T1 AT 07722631 T AT07722631 T AT 07722631T AT 07722631 T AT07722631 T AT 07722631T AT E539351 T1 ATE539351 T1 AT E539351T1
Authority
AT
Austria
Prior art keywords
severity
trauma
rapidly assessing
assessing
rapidly
Prior art date
Application number
AT07722631T
Other languages
English (en)
Inventor
Kristian Bangert
Lars Uttenthal
Original Assignee
Antibodyshop As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38421573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE539351(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Antibodyshop As filed Critical Antibodyshop As
Application granted granted Critical
Publication of ATE539351T1 publication Critical patent/ATE539351T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/42—Poisoning, e.g. from bites or stings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT07722631T 2006-05-30 2007-05-30 Verfahren zur schnellen beurteilung der schwere eines traumas ATE539351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80922806P 2006-05-30 2006-05-30
PCT/DK2007/000254 WO2007137584A1 (en) 2006-05-30 2007-05-30 Methods and devices for rapid assessment of severity of injury

Publications (1)

Publication Number Publication Date
ATE539351T1 true ATE539351T1 (de) 2012-01-15

Family

ID=38421573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07722631T ATE539351T1 (de) 2006-05-30 2007-05-30 Verfahren zur schnellen beurteilung der schwere eines traumas

Country Status (6)

Country Link
US (4) US20090197280A1 (de)
EP (1) EP2035835B1 (de)
AT (1) ATE539351T1 (de)
ES (1) ES2379603T3 (de)
PL (1) PL2035835T3 (de)
WO (1) WO2007137584A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US20090197280A1 (en) 2006-05-30 2009-08-06 Kristian Bangert Methods and Devices for Rapid Assessment of Severity of Injury
US20100210031A2 (en) * 2006-08-07 2010-08-19 Antibodyshop A/S Diagnostic Test to Exclude Significant Renal Injury
US8846036B2 (en) 2007-10-19 2014-09-30 Abbott Laboratories Antibodies that bind to mammalian NGAL and uses thereof
US7977110B2 (en) 2008-06-02 2011-07-12 Children's Hospital Medical Center Method for distinguishing between kidney dysfunctions
CN102759623A (zh) * 2012-07-06 2012-10-31 南京基蛋生物科技有限公司 一种检测ngal胶体金试纸条及其制备方法
JP2016533497A (ja) 2013-07-09 2016-10-27 エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ 放射線傷害の線量評価のためのバイオマーカーパネルおよびマイクロ血漿フィルター
KR101590622B1 (ko) * 2013-10-24 2016-02-01 (주)메디컬그룹베스티안 화상 중증도 판단 방법
JP6572078B2 (ja) * 2015-09-28 2019-09-04 富士フイルム株式会社 ピペットチップおよび液体注入方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686081A (en) 1969-01-31 1972-08-22 Messerschmitt Boelkow Blohm Method for incorporating strength increasing filler materials in a matrix
IT1074038B (it) 1976-08-05 1985-04-17 Simes Esteri della epinina
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4357343A (en) 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
US4502430A (en) 1982-11-08 1985-03-05 Ngk Spark Plug Co., Ltd. Ceramic heater
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
JP2912413B2 (ja) 1990-03-28 1999-06-28 東亜医用電子株式会社 粒度分布作成方法
US5273981A (en) 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
US5405832A (en) 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
SE9401351D0 (sv) 1994-04-21 1994-04-21 Venge A method for diagnosis
US5552313A (en) 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
AU698350B2 (en) * 1995-04-12 1998-10-29 Oy Medix Biochemica Ab Methods and test kits for diagnosis of periodontal diseases and for predicting the risk of progression thereof
US5750345A (en) 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US5627034A (en) 1995-12-05 1997-05-06 Wisconsin Alumni Research Foundation Assay for carcinoma proliferative status by measuring NGAL expression level
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
SI0907735T2 (sl) 1996-05-24 2010-01-29 Biogen Idec Inc Modulatorji tkivne regeneracije
CA2298439A1 (en) 1997-08-06 1999-02-18 Zymogenetics, Inc. Lipocalin homologs
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
AUPP784398A0 (en) 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
AU5330200A (en) 1999-06-18 2001-01-09 Michigan State University Method and apparatus for the detection of volatile products in a sample
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
JP2004502644A (ja) * 2000-03-09 2004-01-29 ジェンザイム、コーポレーション 腎機能の喪失を治療または予防するためのＴＧＦ−β拮抗薬の使用
AU2001293964B2 (en) 2000-10-03 2007-06-14 Rowett Research Institute Method of assaying pyrrole-containing biological compounds
EP1334364A2 (de) 2000-10-13 2003-08-13 Children's Medical Center Corporation Nicht-invasives enzym-screening-verfahren für gewebenumformung-assozierte bedingungen
US20040203083A1 (en) 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
EP1666881B1 (de) 2001-05-04 2010-02-17 Biosite Incorporated Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
EP1300472A1 (de) 2001-10-02 2003-04-09 Stichting Top-Instituut Voedselwetenschappen Verfahren zur Prüfung der Wirkung von Nahrungsmittel, eine Resistenz gegen Kolonisation durch Bakterien zuerzeugen
US6767733B1 (en) * 2001-10-10 2004-07-27 Pritest, Inc. Portable biosensor apparatus with controlled flow
MY151199A (en) 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
US20030119209A1 (en) * 2001-12-21 2003-06-26 Kaylor Rosann Marie Diagnostic methods and devices
US6986995B2 (en) 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
US6847451B2 (en) 2002-05-01 2005-01-25 Lifescan, Inc. Apparatuses and methods for analyte concentration determination
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US7056702B2 (en) 2002-12-16 2006-06-06 Kimberly Clark Co Detecting lipocalin
DE602004022150D1 (de) 2003-03-27 2009-09-03 Childrens Hosp Medical Center Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
JP2007536260A (ja) 2004-05-06 2007-12-13 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 虚血性および腎毒性障害の軽減および改善用ｎｇａｌ
US20050272101A1 (en) 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
NZ555926A (en) * 2004-12-20 2008-11-28 Antibodyshop As Determination of neutrophil gelatinase-associated lipocalin (NGAL) as a diagnostic marker for renal disorders
US8454672B2 (en) 2005-02-11 2013-06-04 Arizant Healthcare Inc. Warming device for perioperative use
US20070037232A1 (en) 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US7806540B2 (en) 2005-08-26 2010-10-05 Ccs, Inc. Illumination device
WO2007044884A1 (en) 2005-10-11 2007-04-19 Dilithium Networks Pty Ltd. Methods and system for fast session establishment for h.324 and related telecommunications terminals
US20080090304A1 (en) 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
AU2007217861A1 (en) 2006-02-17 2007-08-30 Children's Medical Center Corporation Free NGAL as a biomarker for cancer
US20090197280A1 (en) 2006-05-30 2009-08-06 Kristian Bangert Methods and Devices for Rapid Assessment of Severity of Injury
US20090269777A1 (en) 2007-10-19 2009-10-29 Abbott Laboratories Immunoassays and kits for the detection of ngal
WO2009052392A1 (en) 2007-10-19 2009-04-23 Abbott Laboratories Immunoassays and kits for the detection of ngal
US20090123946A1 (en) 2007-10-19 2009-05-14 Abbott Laboratories Immunoassays and kits for the detection of ngal
US20090123970A1 (en) 2007-10-19 2009-05-14 Abbott Laboratories Glycosylated mammalian ngal and use thereof
US20090124022A1 (en) 2007-10-19 2009-05-14 Abbott Laboratories Antibodies that bind to mammalian ngal and uses thereof
WO2009059259A2 (en) 2007-10-31 2009-05-07 Children's Hospital Medical Center Detection of worsening renal disease in subjects with systemic lupus erythematosus
MY162697A (en) 2008-11-21 2017-07-14 Future Medical Diagnostics Co Ltd Methods, devices and kits for detecting or monitoring acute kidney injury

Also Published As

Publication number Publication date
EP2035835B1 (de) 2011-12-28
US20150064730A1 (en) 2015-03-05
PL2035835T3 (pl) 2012-05-31
US20180172710A1 (en) 2018-06-21
ES2379603T3 (es) 2012-04-27
US20150323552A1 (en) 2015-11-12
EP2035835A1 (de) 2009-03-18
US20090197280A1 (en) 2009-08-06
US11125761B2 (en) 2021-09-21
WO2007137584A1 (en) 2007-12-06
US9927446B2 (en) 2018-03-27

Similar Documents

Publication Publication Date Title
ATE539351T1 (de) Verfahren zur schnellen beurteilung der schwere eines traumas
EP2387711A4 (de) Verfahren zur bestimmung von patientenreaktionen durch her-3-messung
EP2131721A4 (de) Vorrichtung und verfahren für objektive sichtfeldumfangstests
ATE554389T1 (de) Apex als marker für lungenkrebs
EP2617061A4 (de) Verfahren und vorrichtung zur analytmessung
DE502006006367D1 (de) Verfahren zum messen einer analytkonzentration in
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
EP2234170A4 (de) Solarbatterie-untersuchungsvorrichtung und verfahren zur beurteilung eines solarbatteriedefekts
DE602007000426D1 (de) Messvorrichtung und Verfahren zur Oberflächentexturmessung
DE502004002547D1 (de) Vorrichtung zum optischen Vermessen eines Objektes
EP1921439A4 (de) Messvorrichtung, messgerät und messverfahren
BRPI0909260A2 (pt) Método de teste ultrassônico e equipamento para o mesmo
EP3835801A4 (de) Vorrichtung zur abschätzung eines batteriezustandes
DE602005007823D1 (de) Verfahren und Vorrichtung zum Messen der Form eines Objekts
WO2010136163A8 (en) Secernin-1 as a marker for cancer
DE602007008027D1 (de) Ultraschalldiagnosevorrichtung und Verfahren zum Messen der Größe eines Zielobjekts
DE112008003644A5 (de) Verfahren zur Endtiterbestimmung und dessen Auswertung mittels indirekten Immunfluoreszenz Test
ATE506890T1 (de) Vorrichtung und verfahren zur vorhersage eines kontrollverlustes über einen muskel
BRPI0812226A2 (pt) dispositivo e método para o teste não destrutivo de objetos
BRPI0922062A2 (pt) aparelho e método de teste ultrassônico.
EP1826553A4 (de) Messeinrichtung
ATE556208T1 (de) Indizieranordnung und verfahren zur bestimmung eines motorkennwertes
AT10236U2 (de) Messanordnung und verfahren zur erfassung von messdaten
WO2013018078A3 (en) Bearing wear detection device
HK1136873A1 (en) Use of nnmt as a marker for lung cancer